Neuronex

Morrisville, United States Founded: 2010 • Age: 16 yrs Acquired By Acorda
Nasal spray formulation of diazepam is developed for seizure disorders.
Request Access

About Neuronex

Neuronex is a company based in Morrisville (United States) founded in 2010 was acquired by Acorda in February 2012.. Neuronex has raised $1.5 million across 2 funding rounds from investors including Acorda. Neuronex operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.

  • Headquarter Morrisville, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Neuronex, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.5 M (USD)

    in 2 rounds

  • Latest Funding Round
    $400 K (USD), Debt – Conventional

    May 06, 2011

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Acorda

    (Feb 17, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Neuronex

Neuronex has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $400 thousand completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Debt – Conventional — $399,999
  • First Round

    (07 Oct 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2011 Amount Debt – Conventional - Neuronex Valuation

investors

Oct, 2010 Amount Series A - Neuronex Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Neuronex

Neuronex has secured backing from 1 investor. Prominent investors backing the company include Acorda. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Engaged in the development and commercialization of therapies that improve neurological function.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Neuronex

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Neuronex

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Neuronex Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Neuronex

Neuronex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Drugs for CNS disorders are developed and advanced.
domain founded_year HQ Location
Developer of therapeutic solutions for the treatment of diabetes
domain founded_year HQ Location
Genetically engineered cell therapies are developed for multiple disorders.
domain founded_year HQ Location
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
domain founded_year HQ Location
Therapies for neurological and neuropsychiatric diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Neuronex

Frequently Asked Questions about Neuronex

When was Neuronex founded?

Neuronex was founded in 2010.

Where is Neuronex located?

Neuronex is headquartered in Morrisville, United States.

Is Neuronex a funded company?

Neuronex is a funded company, having raised a total of $1.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $1.5M, raised on Oct 07, 2010.

What does Neuronex do?

Neuronex was founded in 2010 in Morrisville, United States, as a development-stage company targeting Central Nervous System diseases. A proprietary nasal spray version of diazepam, licensed from SK Biopharmaceuticals, is being developed as rescue medication for patients with seizure disorders. The company was acquired by Acorda in 2012, shifting its operations under the new ownership.

Who are the top competitors of Neuronex?

Neuronex's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.

Who are Neuronex's investors?

Neuronex has 1 investor. Key investors include Acorda.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available